www.zerohedge.com

FDA Advisers Back Maternal RSV Vaccine As Pfizer Says Safety Concerns Can Be Studied Post-Approval | ZeroHedge

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero